Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation

ClinicalTrials.gov ID: NCT00804141

Public ClinicalTrials.gov record NCT00804141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study to Evaluate the Long-Term Safety of Subcutaneous MOA-728 for Treatment of Opioid-Induced Constipation in Subjects With Nonmalignant Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to evaluate the long-term safety and tolerability of the subcutaneous (SC) injection form of N-methylnaltrexone bromide (MOA-728) for the treatment of opioid-induced constipation in participants with nonmalignant pain. The study consists of a 2-week screening period, a 48-week open-label treatment period and a 2 week follow-up period. Participants will need to agree to self-administer SC injections, complete daily diaries, and check-in via a daily telephone call during the study.

Study identification

NCT ID
NCT00804141
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
1,040 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2, 2008
Primary completion
Sep 19, 2010
Completion
Sep 19, 2010
Last update posted
Oct 17, 2019

2008 – 2010

United States locations

U.S. sites
94
U.S. states
33
U.S. cities
79
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35242
Pfizer Investigational Site Chandler Arizona 85224
Pfizer Investigational Site Mesa Arizona 85206
Pfizer Investigational Site Mesa Arizona 85213
Pfizer Investigational Site Phoenix Arizona 85028
Pfizer Investigational Site Phoenix Arizona 85029
Pfizer Investigational Site Tempe Arizona 85282
Pfizer Investigational Site Tucson Arizona 85710
Pfizer Investigational Site Tucson Arizona 85741
Pfizer Investigational Site Hot Springs Arkansas 71913
Pfizer Investigational Site Garden Grove California 92843
Pfizer Investigational Site Laguna Hills California 92653
Pfizer Investigational Site Los Gatos California 95032
Pfizer Investigational Site Newport Beach California 92660
Pfizer Investigational Site Newport Beach California 92663
Pfizer Investigational Site Colorado Springs Colorado 80904
Pfizer Investigational Site Boca Raton Florida 33432
Pfizer Investigational Site Brandon Florida 33511
Pfizer Investigational Site Chiefland Florida 32626
Pfizer Investigational Site Clearwater Florida 33756
Pfizer Investigational Site Daytona Beach Florida 32117
Pfizer Investigational Site Fort Myers Florida 33916
Pfizer Investigational Site Gainesville Florida 32607
Pfizer Investigational Site Jacksonville Florida 32216
Pfizer Investigational Site Jacksonville Florida 32257
Pfizer Investigational Site Jupiter Florida 33458
Pfizer Investigational Site Miami Florida 33180
Pfizer Investigational Site Miami Florida 33183
Pfizer Investigational Site Ocala Florida 34471-2106
Pfizer Investigational Site Ocala Florida 34471
Pfizer Investigational Site Ocala Florida 34474
Pfizer Investigational Site Orlando Florida 32806
Pfizer Investigational Site Ormond Beach Florida 32174
Pfizer Investigational Site Port Orange Florida 32129
Pfizer Investigational Site Sarasota Florida 34231
Pfizer Investigational Site Sarasota Florida 34239
Pfizer Investigational Site Tampa Florida 33603
Pfizer Investigational Site Tampa Florida 33613
Pfizer Investigational Site Vero Beach Florida 32960
Pfizer Investigational Site Winter Park Florida 32789
Pfizer Investigational Site Chicago Illinois 60616
Pfizer Investigational Site Rockford Illinois 61107
Pfizer Investigational Site Avon Indiana 46123
Pfizer Investigational Site Evansville Indiana 47714
Pfizer Investigational Site Indianapolis Indiana 46205
Pfizer Investigational Site Indianapolis Indiana 46250
Pfizer Investigational Site West Des Moines Iowa 50265
Pfizer Investigational Site Madisonville Kentucky 42431
Pfizer Investigational Site Hagerstown Maryland 21742
Pfizer Investigational Site Hollywood Maryland 20636
Pfizer Investigational Site Boston Massachusetts 02115
Pfizer Investigational Site Brockton Massachusetts 02301
Pfizer Investigational Site Watertown Massachusetts 02472
Pfizer Investigational Site Bingham Farms Michigan 48025
Pfizer Investigational Site Chesterfield Michigan 48047
Pfizer Investigational Site Kalamazoo Michigan 49009
Pfizer Investigational Site Traverse City Michigan 49684
Pfizer Investigational Site Edina Minnesota 55435
Pfizer Investigational Site Biloxi Mississippi 39531
Pfizer Investigational Site Jackson Mississippi 39202
Pfizer Investigational Site Springfield Missouri 65807
Pfizer Investigational Site Omaha Nebraska 68131
Pfizer Investigational Site Henderson Nevada 89014
Pfizer Investigational Site Las Vegas Nevada 89119
Pfizer Investigational Site Las Vegas Nevada 89123
Pfizer Investigational Site Las Vegas Nevada 89146
Pfizer Investigational Site Elizabeth New Jersey 07202
Pfizer Investigational Site Albuquerque New Mexico 87102
Pfizer Investigational Site Great Neck New York 11023
Pfizer Investigational Site New York New York 10022
Pfizer Investigational Site Charlotte North Carolina 28204
Pfizer Investigational Site Raleigh North Carolina 27607
Pfizer Investigational Site Fargo North Dakota 58103
Pfizer Investigational Site Centerville Ohio 45459
Pfizer Investigational Site Dayton Ohio 45432
Pfizer Investigational Site Oklahoma City Oklahoma 73112
Pfizer Investigational Site Medford Oregon 97504
Pfizer Investigational Site Portland Oregon 97210
Pfizer Investigational Site Altoona Pennsylvania 16602
Pfizer Investigational Site Levittown Pennsylvania 19056
Pfizer Investigational Site Yardley Pennsylvania 19067
Pfizer Investigational Site Cranston Rhode Island 02920
Pfizer Investigational Site Huntingdon Tennessee 38344
Pfizer Investigational Site Austin Texas 78705
Pfizer Investigational Site Beaumont Texas 77701
Pfizer Investigational Site Dallas Texas 75230
Pfizer Investigational Site Dallas Texas 75234
Pfizer Investigational Site Houston Texas 77074
Pfizer Investigational Site Hurst Texas 76054
Pfizer Investigational Site San Antonio Texas 78215
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site Salt Lake City Utah 84106
Pfizer Investigational Site Christiansburg Virginia 24073
Pfizer Investigational Site Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00804141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 17, 2019 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00804141 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →